Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-13 Sale |
2025-03-17 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
3,231 | $510 | $1,647,810 | 23,281 (Direct) |
View |
| 2025-03-10 Sale |
2025-03-12 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
3,231 | $500 | $1,615,500 | 26,512 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
3,231 | $490 | $1,583,190 | 29,743 (Direct) |
View |
| 2025-02-27 Sale |
2025-02-28 4:23 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
1,272 | $480 | $610,560 | 32,974 (Direct) |
View |
| 2025-02-25 Sale |
2025-02-26 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
848 | $480.95 | $407,846 | 40,200 (Direct) |
View |
| 2025-02-20 Sale |
2025-02-24 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
1,111 | $480 | $533,280 | 45,019 (Direct) |
View |
| 2024-11-15 Sale |
2024-11-19 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
15 | $478.56 | $7,178 | 25,813 (Direct) |
View |
| 2024-05-15 Sale |
2024-05-17 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
54 | $430.93 | $23,270 | 25,813 (Direct) |
View |
| 2024-02-26 Sale |
2024-02-27 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,239 | $425.7 | $1,804,542 | 25,813 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-23 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,002 | $421.77 | $1,266,154 | 34,022 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,002 | $420.79 | $1,684,002 | 37,024 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-13 4:46 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,145 | $420.24 | $1,321,655 | 47,588 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-17 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
19 | $369.92 | $7,028 | 32,038 (Direct) |
View |
| 2023-08-09 Sale |
2023-08-11 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
63 | $345.51 | $21,767 | 32,038 (Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 4:40 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,238 | $287.51 | $1,218,449 | 32,038 (Direct) |
View |
| 2023-02-21 Sale |
2023-02-22 4:25 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,002 | $293.77 | $1,175,676 | 40,246 (Direct) |
View |
| 2023-02-14 Sale |
2023-02-16 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
6,398 | $298.7 | $1,911,108 | 47,998 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-14 4:49 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,798 | $298.9 | $1,434,126 | 54,396 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 4:53 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $306 | $399,022 | 68,645 (Direct) |
View |
| 2022-11-15 Sale |
2022-11-17 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
34 | $308.61 | $10,493 | 36,077 (Direct) |
View |
| 2022-11-07 Sale |
2022-11-09 4:40 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,303 | $303.04 | $394,859 | 37,381 (Direct) |
View |
| 2022-08-08 Sale |
2022-08-10 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $292.54 | $381,469 | 38,684 (Direct) |
View |
| 2022-07-19 Sale |
2022-07-21 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
17,865 | $288.65 | $5,156,730 | 39,988 (Direct) |
View |
| 2022-02-25 Sale |
2022-02-28 5:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
7,572 | $230.98 | $1,748,990 | 36,077 (Direct) |
View |
| 2022-02-18 Sale |
2022-02-22 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,312 | $230.97 | $995,949 | 49,687 (Direct) |
View |
| 2022-02-14 Sale |
2022-02-16 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,444 | $232.02 | $567,057 | 57,438 (Direct) |
View |
| 2022-02-11 Sale |
2022-02-14 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,297 | $235.02 | $539,837 | 59,882 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,660 | $251.47 | $1,171,842 | 65,697 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-16 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
34 | $187.22 | $6,365 | 33,589 (Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 4:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
79 | $216.36 | $17,093 | 33,589 (Direct) |
View |
| 2021-02-25 Sale |
2021-02-26 4:03 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,028 | $213.39 | $646,139 | 33,589 (Direct) |
View |
| 2021-02-18 Sale |
2021-02-19 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
7,825 | $211.83 | $1,657,590 | 39,033 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
5,283 | $210.54 | $1,112,274 | 53,098 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-26 Tax Withholding |
2025-02-28 4:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
5,954 | $479.61 | 32,974 (Direct) |
View |
| 2025-02-24 Tax Withholding |
2025-02-26 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
3,971 | $483.28 | 40,200 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
2,293 | $463.46 | 46,130 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
5,324 | $0 | 48,423 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
2,142 | $467.98 | 43,099 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
19,428 | $0 | 45,241 (Direct) |
View |
| 2024-02-23 Tax Withholding |
2024-02-27 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,970 | $431.79 | 25,813 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-21 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,750 | $424.01 | 37,024 (Direct) |
View |
| 2024-02-20 Tax Withholding |
2024-02-21 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,812 | $420.58 | 37,024 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,099 | $422.74 | 47,588 (Direct) |
View |
| 2024-02-06 Option Award |
2024-02-08 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
20,794 | $0 | 52,832 (Direct) |
View |
| 2023-02-24 Tax Withholding |
2023-02-28 4:40 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,970 | $289.12 | 32,038 (Direct) |
View |
| 2023-02-17 Tax Withholding |
2023-02-22 4:25 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,750 | $292.85 | 40,246 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,461 | $294.33 | 54,396 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-14 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
5,990 | $298.26 | 54,396 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:53 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $187.53 | 68,645 (Direct) |
View |
| 2023-02-06 Exercise |
2023-02-08 4:53 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $0 | 68,645 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:30 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
32,568 | $0 | 68,645 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 4:40 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,303 | $187.53 | 37,381 (Direct) |
View |
| 2022-11-07 Exercise |
2022-11-09 4:40 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,303 | $0 | 37,381 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-10 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $187.53 | 38,684 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-10 4:06 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,304 | $0 | 38,684 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
7,338 | $155.57 | 39,988 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
10,427 | $187.53 | 39,988 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 4:48 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
17,765 | $0 | 39,988 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 5:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
6,038 | $227.86 | 36,077 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,439 | $232.51 | 49,687 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:11 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,518 | $237.74 | 59,882 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
32,108 | $0 | 65,697 (Direct) |
View |
| 2022-02-02 Exercise |
2022-02-03 4:06 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,660 | $86.52 | 65,697 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,416 | $217.57 | 33,589 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
6,240 | $211.75 | 39,033 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,974 | $214.16 | 58,381 (Direct) |
View |